22.01.2023 | Tracker

Respiratory tracker: eHCPs focus on paediatric cases

By Mark Sullivan

With the start of a new year, January not only welcomes in 2023 but also a new look Respiratory tracker. CREATION.co has identified the increasing attention towards Respiratory syncytial virus (RSV) and with eHCPs taking a front row seat to the Pharma race for an RSV vaccine, the respiratory tracker of 2023 will have a focus towards the developments in this therapy area. On-brand with this, the most active UK eHCP discussing respiratory diseases this month also posted the most about RSV – Dr Kate Cushing had a total of 38 respiratory disease posts, with 18 mentioning RSV. In total CREATION Pinpoint® identified 1,502 UK eHCPs discussing respiratory diseases in 2,799 posts.

Within the RSV conversation, eHCPs noted that the similar rates of hospitalisation and mortality between RSV and influenza in older adults suggests how important it is for a vaccine to be developed for the disease. Whilst another eHCP shared his opinion that as RSV immunisations get closer to implementation, there is a need for genomic data to assess effectiveness. A hefty proportion of the UK eHCP RSV conversation also mentioned COVID-19 (46%), with eHCPs sharing their frustration at the lack of public health measures in place to try and control the surge in influenza, RSV and COVID-19.

A theme that was identified throughout the month was a focus towards paediatric respiratory diseases, with many UK eHCPs referencing different factors which could predispose children to increased risk of respiratory diseases. This focus came following an increase in childhood group A streptococcal infections as well as growing levels of respiratory viral infections, including, but not limited to, RSV & influenza. This subject matter was extended by eHCPs disseminating research from 2015, which highlighted the different variables between households who experienced dissimilar levels of childhood respiratory infection rates. 

Additionally, UK eHCPs took to discussing more recent studies regarding childhood respiratory diseases. One study which garnered particular eHCP attention assessed the relationship between gas stoves and childhood asthma cases, a study which Digital Opinion Leader Ash Paul also shared. This was not the only latest research to be shared amongst eHCPs this month as many also discussed evidence for early interventions to reduce childhood respiratory diseases, as well as current findings regarding smoking exposure in early life contributing to lung cancer incidence and mortality in adulthood. 

COVID-19 was mentioned 534 times this month with eHCPs highlighting the increased rates amongst the UK population. eHCPs implored the public to take precautionary measures to ensure the disease would not spread, including wearing masks and avoiding crowded places. Much of this was accepted and encouraged amongst eHCPs, however, some did disagree with GP Renée Hoenderkamp stating she was “horrified” at the reintroduction of restrictions for flu and other respiratory illness. On the other hand, eHCPs shared the increased rates of COVID-19 and linked them to Hospital-acquired COVID-19 in England.

Each month, we track the HCP conversation relating to respiratory disease.

You can keep up to date with this and other pharmaceutical tracking updates, including COVID-19 developments, within the Tracking section of CREATION Knowledge, or sign up to receive our monthly eJournal with all of our latest HCP insights. 

If you would like to dig deeper into what we have seen this month then please do get in touch.

Methodology

  • This article analysed the Twitter conversations of HCPs in the UK discussing respiratory disease and related terms between 21 December 2022 and 20 January 2023 using CREATION Pinpoint®.
  • Between 21 December 2022 and 20 January 2023, there were 2,779 UK HCP mentions of respiratory disease and related terms, from 1,502 unique UK HCP authors. 

Click here to read the latest Respiratory Tracker

 

View all articles >

Meet the Author

Mark Sullivan

Mark uses his passion for data analysis to study the online conversations of HCPs and find actionable insights which are presented to teams in the pharmaceutical industry so they can make informed decisions.

Mark is an avid sports fan whether watching or playing. He enjoys spending time with his family and friends and watching films.

Suggested next


Top 50 Pharma Tracker: HCPs mentioning Pharma in Relation to COVID-19

01.04.2020 | Article

Top 50 Pharma Tracker: HCPs mentioning Pharma in Relation to COVID-19

Top 50 Pharma Tracker: HCPs mentioning Pharma in Relation to COVID-19

By Mary Kangley

27.08.2020 | Article

Shifting sentiment towards online consultations

What do healthcare professionals think about online consultations?

By Jamie Doggett

View all articles >